InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by RODRIGUEZ RAUL R, Chairman & CEO. Director active across 1 companies, notably RIGEL PHARMACEUTICALS INC. Aggregated, 3 disclosures have been published. Total volume traded: €648k. The latest transaction was filed on 9 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
€648,2591,000,000 shares@ €0.64830.12% mcap100.0% of flow
Common Stock
SEC:0001567619-22-012778:0·
Ideal exit: 6 Mar 2023 (T+270)
0200,000 shares0
Common Stock
SEC:0001567619-22-001779·
0200,000 shares0
Common Stock
SEC:0001567619-22-001779:0·
3 of 3 declarations
About RODRIGUEZ RAUL R
RODRIGUEZ RAUL R is the CEO and President of RIGEL PHARMACEUTICALS INC. He leads the company and oversees its operations, ensuring it meets its strategic objectives. His experience in the pharmaceutical sector is essential in guiding the organization towards sustainable growth and continuous innovation.
